Aprea Therapeutics Inc (NAS:APRE)
$ 0.65 +0.018 (+2.81%) Market Cap: 8.05 Mil Enterprise Value: -38.41 Mil PE Ratio: 0 PB Ratio: 0.19 GF Score: 32/100

Aprea Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2026 / 01:00PM GMT
Release Date Price: $0.7293 (+4.39%)
Operator

Hello and welcome to the Annual Meeting of Stockholders of Aprea Therapeutics. Please note that today's meeting is being recorded.

It is now my pleasure to turn today's meeting over to Dr. Oren Gilad, President and Chief Executive Officer of the company. Please go ahead, sir.

Oren Gilad
Aprea Therapeutics Inc - President, Chief Executive Officer, Director

Thank you, operator, and good morning. This meeting is officially called to order. I'm Oren Gilad, President and CEO of the company, and I will be presiding as Chairman of this meeting. I want to welcome you to the 2026 Annual Meeting of the Stockholders of Aprea Therapeutics, Inc.

John Hamill, Senior Vice President and Chief Financial Officer of the company, will act as Secretary of the meeting. We have chosen to conduct this annual meeting in a virtual format, and we're pleased to be able to hold a meeting that a stockholder can attend virtually from anywhere, enabling everyone to engage with the company.

And with that, I will turn the meeting over to the Secretary for some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot